Scilex Holding Company Ttl Fee Amt
Scilex Holding Company (SCLX) had Ttl Fee Amt of $1.23 thousand as of 2026-06-29, per its S-8 filed 2026-06-30.
Financial Statements › Notes
ffd:TtlFeeAmt · last filed 2026-06-30
- 2026-06-29: Ttl Fee Amt $1.23K.
- 2026-04-22: Ttl Fee Amt $276.20.
- 2026-04-10: Ttl Fee Amt $69.05K.
| Period end | Ttl Fee Amt |
|---|---|
| 2026-06-29 | $1.23K S-8 · filed 2026-06-30 |
| 2026-04-22 | $276.20 S-3 · filed 2026-06-02 |
| 2026-04-10 | $69.05K S-3 · filed 2026-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |